VR treatment for amblyopia

The US Food and Drug Administration has approved a virtual reality-based treatment for amblyopia in children, the company behind the treatment announced today. Patients watch modified TV shows or movies with virtual reality headsets to improve their vision.
"We are proud of FDA's groundbreaking decision today to approve the first digital treatment that allows patients to watch their favorite TV shows and movies to improve their vision," Scott Shaluminopia, CEO of the company that developed the tool, said in a statement.
About 3 percent of children have amblyopia, which occurs when the brain and eyes stop communicating normally. The brain favors one eye, causing vision problems in the other. This is the leading cause of vision problems in children. Treatment is usually done by blocking the stronger eye with an eye patch or blurring lotion, forcing the brain to rely on the weaker eye.

Luminopia's approach uses television and movies to cultivate the amblyopic eye and train the eyes to work together. Patients watch shows or movies through headphones and images are shown to each eye separately. The stronger eye saw the images with lower contrast, and the images were stacked on top of each other, forcing the brain to use both eyes to see them properly.
In clinical trials of the technology, children who used the treatment and wore glasses showed greater improvement in vision than a group of children who did not use the treatment but wore corrective glasses full-time. After 12 weeks of one-hour a day, six days a week program therapy, 62 percent of the children had a significant improvement in their vision. Only about a third of the children in the control group showed similar improvements over the 12-week course.
Luminopia, which has more than 700 hours of programming in its library, developed the tool in partnership with children's content distributors such as Nelvana and Sesame Workshop. The authors of the clinical trial wrote that they thought the choice of popular videos might be one reason users stuck with the program -- people followed the treatment plan 88 percent of the time. Less than 50% of patients insist on using an eye mask or blur lotion.
With the approval, Luminopia is one of only a handful of companies approved to offer digital treatments as prescription treatments for medical conditions. Last year, the FDA approved a prescription video game called Endeavour RX to treat ADHD in children ages 8 to 12.
Luminopia plans to launch the therapy in 2022, it said in a statement.

Inquiry us

Our Latest Products

CAS No. 557-05-1 40% Water-based Zinc Stearate Zinc Stearate Emulsion

Product DescriptionProduct Description Description of zinc stearate emulsionZinc stearate emulsion is easy to disperse in water, has ultra-fineness, good dispersion compatibility. Zinc stearate emulsion has the characteristics of lubricating and deli...…

China factory cheapest price lightweight concrete wall panel making machine large hydraulic cement foaming machine equipment

Product performance of TR-40 Cement Foaming Machine1. The shell is made of high-strength precision thickened steel plate, painted twice, which is durable.2. The slurry output is uniform and stable, the density of the foam concrete finished product i...…

TR30 huge CLC concrete foam generator cement foaming machine Integrated machine for pouring light steel keel and structural wall

Company Profile Luoyang Tongrun Info Technology Co., Ltd. is committed to technology development, applications of nanotechnology and new material industries, with professional experience in the nano-technology research and developmen...…

0086-0379-64280201 brad@ihpa.net skype whatsapp